Chemical Industry Eli Lilly Deepens Investment in Hard-to-Drug Therapeutics with Expanded Up-to-$870m Gate Bioscience Partnership INDIANAPOLIS & SOUTH SAN FRANCISCO — Pharmaceutical giant Eli Lilly and Company is doubling down… AsroOctober 6, 2026
